Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.26 USD | -0.58% | -2.73% | -9.57% |
Mar. 18 | Gilead Sciences Receives a Shareholder Proposal from Jing Zhao | CI |
Mar. 14 | Gilead Sciences, Inc. Announces Retirement of Kevin E. Lofton from the Board, Effective May 8, 2024 | CI |
Financials (USD)
Sales 2024 * | 27.51B | Sales 2025 * | 28.03B | Capitalization | 91.27B |
---|---|---|---|---|---|
Net income 2024 * | 6.54B | Net income 2025 * | 6.86B | EV / Sales 2024 * | 3.75 x |
Net Debt 2024 * | 11.84B | Net Debt 2025 * | 4.96B | EV / Sales 2025 * | 3.43 x |
P/E ratio 2024 * |
14.1
x | P/E ratio 2025 * |
13.2
x | Employees | 18,000 |
Yield 2024 * |
4.28% | Yield 2025 * |
4.47% | Free-Float | 99.91% |
Latest transcript on Gilead Sciences, Inc.
1 day | -0.58% | ||
1 week | -2.48% | ||
Current month | +1.61% | ||
1 month | +2.35% | ||
3 months | -8.80% | ||
6 months | -3.18% | ||
Current year | -9.57% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 58 | 19-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 54 | 15-12-31 |
Flavius Martin
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Welters
BRD | Director/Board Member | 69 | 20-10-16 |
Director/Board Member | 71 | 17-12-31 | |
Ted Love
BRD | Director/Board Member | 65 | Jan. 31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.99% | 227 M€ | +9.20% | - | |
8.10% | 0 M€ | 0.00% | - | |
8.06% | 0 M€ | 0.00% | - | |
5.23% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 73.26 | -0.58% | 6,937,786 |
24-03-15 | 73.69 | -0.70% | 13,963,774 |
24-03-14 | 74.21 | -2.28% | 8,399,270 |
24-03-13 | 75.94 | +1.15% | 6,003,025 |
24-03-12 | 75.08 | -0.32% | 7,056,289 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.57% | 91.8B | |
+30.83% | 679B | |
+30.96% | 589B | |
+0.01% | 381B | |
+15.18% | 314B | |
+11.39% | 308B | |
+0.78% | 212B | |
-6.09% | 210B | |
-2.92% | 203B | |
-3.72% | 158B |